Raymond schinazi net worth

Author: feug

August undefined, 2024

WebApr 7, 2011 · Emory University professor Raymond F. Schinazi earned $45.4 million this week as his 1.6 million shares of Pharmasset (VRUS) ... Schinazi's stake is now worth … WebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least Precision BioSciences stock worth over $9,440,201 and over the last 8 years Raymond sold DTIL stock worth over $1,696,250

Schinazi Raymond F Net Worth (2024) - GuruFocus.com

WebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least $15 Million dollars as of 4 May 2024. Raymond Schinazi owns over 575,000 units of Precision BioSciences stock worth over $13,277,681 and over the last 7 years Raymond sold DTIL stock worth over $1,696,250. WebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least Precision BioSciences stock worth over $8,979,703 and over the last 8 years Raymond sold DTIL stock worth over $1,696,250 dynasty warriors 3 bodyguard

Raymond F Schinazi Net Worth (2024) Cocrystal Pharma, Inc …

WebIn this section, we analyze the profitability of every unplanned, open-market insider purchase made by Raymond F Schinazi in COCP / Cocrystal Pharma Inc. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are ... WebRaymond F Schinazi Net Worth 2024 and insider trades. Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, ... S&P 500 Aggregate Buffett-Munger Screener Industry Overview Undervalued Predictable Benjamin Graham Net-Net 52-week/3Y/5Y Lows 52-week/3Y/5Y Highs Magic Formula (Greenblatt) ... Raymond F. Schinazi is an American organic medicinal chemist with expertise in antiviral agents, pharmacology, and biotechnology. His research focuses on developing treatments for infections caused by human immunodeficiency virus (HIV), hepatitis B (HBV), hepatitis C (HCV), herpes, dengue fever, zika, chikungunya, and other emerging viruses. These treatment options include antiviral agents as well as synthetic, biochemical, pharmacological and molecular genetic approaches, in… dynasty warrior guan yu

Pharmasset science founder lands a fortune from $11B Gilead …

Raymond Schinazi Net Worth, Biography, and Insider Trading

WebMay 20, 2024 · Nadira Schinazi, M.B.A. ’08, and Raymond F. Schinazi, Ph.D. The endowment will allow Dr. Stevenson to continue his research, which has defined the fundamental features of HIV that make it unique among retroviruses, as well as the principles that underscore HIV's ability to establish a lifelong infection in the host, something that is … WebAug 20, 2015 · Raymond Schinazi, drug-development pioneer, earns VA's highest honor for biomedical research. August 20, 2015. Dr. Raymond Schinazi, a researcher with the Atlanta VA and Emory University, received VA's 2015 Middleton Award for his development of drugs to treat HIV, hepatitis B, and hepatitis C infections. csa high vis dynasty warriors 2004 video game

"WebHis net worth has been growing significantly in 2024-2024. So, how much is Raymond F. Schinazi worth at the age of 70 years old? Raymond F. Schinazi’s income source is … " - Raymond schinazi net worth

Raymond schinazi net worth

Raymond F. Schinazi Biography, Age, Height, Wife, Net Worth, Family

WebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least $8.68 Million dollars as of 4 May 2024. Raymond Schinazi owns over 575,000 units of Precision BioSciences stock worth over $6,984,214 and over the last 8 years Raymond sold DTIL … WebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least Precision BioSciences stock worth over $8,826,204 and over the last 8 years Raymond sold DTIL …

Did you know?

WebDisclamer: Raymond F. Schinazi net worth are calculated by comparing Raymond F. Schinazi's influence on Google, Wikipedia, Youtube, Twitter, Instagram and Facebook with … http://www.nonprofitfacts.com/GA/Raymond-F-Schinazi-And-Family-Foundation-Inc.html

WebSep 5, 2024 · Professor Raymond Schinazi is a scientist whose research focuses on developing treatments for life-threatening viruses. He’s widely recognised for his contributions in the fields of HIV and hepatitis B. In fact, more than 94% of HIV-infected individuals take at least one of the drugs he invented. WebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least $15 Million dollars as of 4 May 2024. Raymond Schinazi owns over 575,000 units of Precision …

WebRaymond F. Schinazi’s income source is mostly from being a successful . He is from Egypt. We have estimated Raymond F. Schinazi's net worth , money, salary, income, and assets. Net Worth in 2024. $1 Million - $5 Million. Salary in 2024. Under Review. WebPharmasset science founder lands a fortune from $11B Gilead buyout Fierce Biotech. Fierce Pharma. Fierce Biotech. Fierce Healthcare. Fierce Life Sciences Events. Research. …

WebRaymond F Schinazi And Family Foundation Inc: Employer Identification Number (EIN) 203693012: ... Net investment income Adjusted net income Disbursements for charitable purposes ... Net value of noncharitable-use assets: $3,320,124: $9,866,296: Minimum investment return: $74,504: $166,006:

WebMay 8, 2015 · In 2005, an anti-HIV drug he helped develop, FTC, netted $540 million for Emory—which gave $71 million to Schinazi. Emory and Schinazi have made millions more in royalty fees for a sister drug, 3TC, which treats both HIV and hepatitis B. And Schinazi, who also runs a lab at Atlanta's VA Medical Center, had a hand in two other drugs on the market. dynasty warriors 2 gundamWebOct 1, 2024 · Raymond Schinazi: Emory University: 1997: US$154 642: US$241 942: 5R01AI041980-02: 1998: US$205 182: US$316 090: ... Schinazi and colleagues, including ... and Exchange Commission; 2011. Offer to Purchase All Outstanding Shares of Common Stock of Pharmasset, Inc. at US$137 Net Per Share in Cash by Royal Merger Sub Inc. and … dynasty warriors 3 how to unlock zhuge liangWebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least Precision BioSciences stock worth over $11,665,939 and over the last 8 years Raymond sold DTIL … dynasty warriors 3 item locationsWebJul 27, 2014 · Gilead has offered to supply the Egyptian government with Sovaldi at a price equivalent to $900 for a curative course of treatment, little more than 1 per cent of the US cost. “What is happening ... dynasty warriors 3 on pcWebSchinazi is the founder of several biotechnology companies focusing on antiviral drug discovery and development, including Pharmasset Inc., Triangle Pharmaceuticals (acquired by Gilead in 2003), Idenix Pharmaceuticals (51% acquired by Novartis in 2003), and RFS Pharma LLC (formed in Sept 2004). He holds more than 70 US patents. csa helpline numberWebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least Precision BioSciences stock worth over $8,749,454 and over the last 8 years Raymond sold DTIL … dynasty warriors 3 isoWebContact & Personal Details. Relatives & Associates. Raymond Schinazi was born on 03/21/1950 and is 71 years old. Raymond Schinazi currently lives in Tucker, GA; in the … dynasty warriors 34